CANCER OF OVARY
Clinical trials for CANCER OF OVARY explained in plain language.
Never miss a new study
Get alerted when new CANCER OF OVARY trials appear
Sign up with your email to follow new studies for CANCER OF OVARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising cancer drug study halted early: what happened?
Disease control TerminatedThis study tested a drug called Promitil in 19 people with ovarian or pancreatic cancer that had specific genetic changes (BRCA or HRD mutations) and had stopped responding to first treatment. The goal was to see if Promitil could slow or stop cancer growth. The study was ended e…
Matched conditions: CANCER OF OVARY
Phase: PHASE2 • Sponsor: Lipomedix Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or combined with other cancer drugs (olaparib or enzalutamide), in people with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The study was…
Matched conditions: CANCER OF OVARY
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 04, 2026 16:31 UTC